Iquest
At a glance
Iquest filed 26 disclosures in the last 12 months, including 3 insider, 3 buyback and 1 5% holder. The most recent key filing was on Sep 29.
Revenue for 2025 was ₩43.6B, up 7.2% on 2024. Operating margin was 9.8% against 8.4% a year earlier. Debt was 88% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩20.9B and operating profit of ₩1.5B.
The 2025 annual report lists 107 employees with an average tenure of 7.7 years and average pay of ₩52.7M, #1327 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩160M each on average. It paid ₩70 per common share in cash dividends, against ₩43 a year earlier (+62.8%). 김순모 and related parties held 40.37% at year end.
From the 2025 annual report
Staff: 107 (56 men, 51 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩5.6B. Directors and auditors: 4, paid ₩641M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩70 | ₩43 | ₩100 |
| Payout ratio | 25.5% | 21.2% | 29.7% |
| Yield (as filed) | 4.10% | 1.80% | 1.80% |
| Total cash dividends | ₩1.4B | ₩798M | ₩943M |
Largest shareholder
김순모 holds 36.97%; with 4 related parties the group holds 40.37% of common shares at year end (from 40.10% at the start of the year).
Auditor: 대주회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.